Skip to main content

Table 1 Disease areas covered by included systematic reviews (the HTA data were collected for this study; the other data are from Page et al. [1])

From: Nature and reporting characteristics of UK health technology assessment systematic reviews

Disease area

HTAs 2004 & 2014

Systematic reviews 2004 [1]a

Systematic reviews 2014 [1]a

Neoplasms (i.e. cancers, carcinomas, tumours)

8 (16%)

22 (7%)

49 (16%)

Diseases of the circulatory system

8 (16%)

33 (11%)

34 (11%)

Endocrine, nutritional or metabolic disease

7 (14%)

NR

23 (8%)

Mental and Behavioural

5 (10%)

40 (13%)

22 (7%)

Infections and parasitic diseases

3 (6%)

22 (7%)

41 (14%)

Diseases of the nervous system

3 (6%)

NR

NR

Musculoskeletal

3 (6%)

NR

20 (7%)

Diseases of the eye and adnexa

2 (4%)

NR

NR

External causes of mortality and morbidity

2 (4%)

NR

NR

Genito-urinary

2 (4%)

NR

NR

Diseases of the digestive system

2 (4%)

20 (7%)

25 (8%)

Ear and mastoid process

1 (2%)

NR

NR

Pregnancy and birth

1 (2%)

NR

NR

Blood

1 (2%)

NR

NR

Skin and subcutaneous tissue

1 (2%)

NR

NR

Congenital malformations

1 (2%)

NR

NR

Total

50 (100%)

137b

214b

  1. HTA Health Technology Assessment; aAs reported by Page et al. [1] bPage et al. did not report values less than 7% so not all 300 systematic reviews are included; NR: Not reported